FR2647346B1 - Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament - Google Patents

Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament

Info

Publication number
FR2647346B1
FR2647346B1 FR8907008A FR8907008A FR2647346B1 FR 2647346 B1 FR2647346 B1 FR 2647346B1 FR 8907008 A FR8907008 A FR 8907008A FR 8907008 A FR8907008 A FR 8907008A FR 2647346 B1 FR2647346 B1 FR 2647346B1
Authority
FR
France
Prior art keywords
compound
medicament
stabilized
preparing
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8907008A
Other languages
English (en)
Other versions
FR2647346A1 (fr
Inventor
Roseline Duclos
Anne-Marie Orecchioni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Besins Iscovesco SA
Original Assignee
Laboratoires Besins Iscovesco SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Besins Iscovesco SA filed Critical Laboratoires Besins Iscovesco SA
Priority to FR8907008A priority Critical patent/FR2647346B1/fr
Publication of FR2647346A1 publication Critical patent/FR2647346A1/fr
Application granted granted Critical
Publication of FR2647346B1 publication Critical patent/FR2647346B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8907008A 1989-05-29 1989-05-29 Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament Expired - Fee Related FR2647346B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8907008A FR2647346B1 (fr) 1989-05-29 1989-05-29 Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8907008A FR2647346B1 (fr) 1989-05-29 1989-05-29 Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament

Publications (2)

Publication Number Publication Date
FR2647346A1 FR2647346A1 (fr) 1990-11-30
FR2647346B1 true FR2647346B1 (fr) 1991-09-06

Family

ID=9382096

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8907008A Expired - Fee Related FR2647346B1 (fr) 1989-05-29 1989-05-29 Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament

Country Status (1)

Country Link
FR (1) FR2647346B1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778922B2 (en) 2009-01-08 2014-07-15 Lipocine Inc. Steroidal compositions
US9205057B2 (en) 2010-11-30 2015-12-08 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US11433083B2 (en) 2010-11-30 2022-09-06 Lipocine Inc. High-strength testosterone undecanoate compositions
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778922B2 (en) 2009-01-08 2014-07-15 Lipocine Inc. Steroidal compositions
US8865695B2 (en) 2009-01-08 2014-10-21 Lipocine Inc. Steroidal compositions
US9949985B2 (en) 2010-11-30 2018-04-24 Lipocine Inc. High-strength testosterone undecanoate compositions
US10799513B2 (en) 2010-11-30 2020-10-13 Lipocine Inc. High-strength testosterone undecanoate compositions
US9480690B2 (en) 2010-11-30 2016-11-01 Lipocine Inc. High-strength testosterone undecanoate compositions
US11433083B2 (en) 2010-11-30 2022-09-06 Lipocine Inc. High-strength testosterone undecanoate compositions
US9757390B2 (en) 2010-11-30 2017-09-12 Lipocine Inc. High-strength testosterone undecanoate compositions
US9943527B2 (en) 2010-11-30 2018-04-17 Lipocine Inc. High-strength testosterone undecanoate compositions
US9205057B2 (en) 2010-11-30 2015-12-08 Lipocine Inc. High-strength testosterone undecanoate compositions
US10226473B2 (en) 2010-11-30 2019-03-12 Lipocine Inc. High-strength testosterone undecanoate compositions
US10716794B2 (en) 2010-11-30 2020-07-21 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US10881671B2 (en) 2010-11-30 2021-01-05 Lipocine Inc. High-strength testosterone undecanoate compositions
US10973833B2 (en) 2010-11-30 2021-04-13 Lipocine Inc. High-strength testosterone undecanoate compositions
US11311555B2 (en) 2010-11-30 2022-04-26 Lipocine Inc. High-strength testosterone undecanoate compositions
US11364249B2 (en) 2010-11-30 2022-06-21 Lipocine Inc. High-strength testosterone undecanoate compositions
US11364250B2 (en) 2010-11-30 2022-06-21 Lipocine Inc. High-strength testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Also Published As

Publication number Publication date
FR2647346A1 (fr) 1990-11-30

Similar Documents

Publication Publication Date Title
PT86182A (en) Process for the preparation of 3-pyrrolidinylthio-1-azabicyclo]3,2,o"hept-2-ene-2-carboxylic acid compounds
MA21962A1 (fr) Procede pour la preparation d'inhibiteurs de proteass retrovirales .
IL95946A0 (en) Preparation of tetrabromo-4,4'-alkylidenediphenols
EP0249530A3 (en) Process for the preparation of glyoxal monoacetals
HU901428D0 (en) Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives
FR2647346B1 (fr) Compose de progesterone stabilisee, procede pour sa preparation, et utilisation de ce compose pour l'obtention d'un medicament
FI894546A (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
OA07202A (fr) Procédé pour la préparation de l'urée
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
FR2630735B1 (fr) Procede de preparations d'halogenophenols
EP0389110A3 (en) Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
FR2453184B1 (fr) Composant de titane catalytique, procede pour la preparation de celui-ci et procede de polymerisation d'alcenes-1 en utilisant un composant de titane de ce type
FR2633273B1 (fr) Procede de preparation de tetraflurorure d'uranium
FR2619676B3 (fr) Pulverisateur, notamment pour l'agriculture
IL92465A0 (en) Process for the preparation of 4,4'-dibromodiphenylether
EG18954A (en) New bronchospasmolytic compounds and process for their preparation
PT81976A (en) Process for the preparation of a new agrochemical named "substance no. 51262"
FR2540492B1 (fr) Procede pour la preparation d'oxime ethers basiques
EP0253413A3 (en) New antibiotics called "mureidomycins a, b, c and d" a process for their preparation and their therapeutic use
FR2630741B1 (fr) Procede de preparation d'acryloyloxyethoxymethyl-melamines
FR2634765B1 (fr) Procede pour la preparation de levo- et de dextro-dropropizine
PT85518A (en) Process for the preparation of antibacterial 7-oxo-4-thia-1-aza-bicyclo ]3.2.o" hept-2-ene derivatives
DE3666804D1 (en) Process for the preparation of 4,4'-dihydroxydiphenyl ether
OA07201A (fr) Procédé pour la préparation de l'urée .

Legal Events

Date Code Title Description
ST Notification of lapse